Baseline characteristics of all subjects, and subjects randomised to active supplement or placebo
| Age, years | DM duration, years | HbA1c % | Gender | DM subtype | DR status | MVM use | |
|---|---|---|---|---|---|---|---|
| Total group (n=67) | 56.1±13.2 | 16±11.2 | 7.2±1.1 | 42 Female 25 Male | 27 T1DM 40 T2DM | No DR=37 Mild DR=24 Mod DR=6 | 23 Yes 44 No |
| DiVFuSS supplement (n=39) | 53.5±14.6 | 16±12.2 | 7.1±1.0 | 26 Female 13 Male | 16 T1DM 23 T2DM | No DR=24 Mild DR=10 Mod DR=5 | 15 Yes 24 No |
| Placebo (n=28) | 59.7±10.3 | 16.1±9.9 | 7.3± 1.1 | 16 Female 12 Male | 11 T1DM 17 T2DM | No DR=13 Mild DR =14 Mod DR=1 | 8 Yes 20 No |
p Values for all baseline characteristics were not statistically significantly different comparing supplemented vs placebo groups (p<0.5).
DiVFuSS, Diabetes Visual Function Supplement Study; DM, diabetes mellitus; DR, diabetic retinopathy; MVM, multivitamin and mineral; T1DM, type 1 diabetes mellitus; T2DM, type 2 diabetes mellitus.